Introduction to Gamma Knife Radiosurgery Training Course- January 13-16, 2020

Miami, FL US
January 13, 2020 to January 16, 2020

The Miami Cancer Institute Department of Radiation Oncology and the Florida International University Herbert Wertheim College of Medicine are pleased to present this Introduction to Gamma Knife® Radiosurgery Training Course for radiation oncologists, neurosurgeons, medical physicists, neuro-otolaryngologists, and other healthcare professionals interested in Gamma Knife radiosurgery training.

This educational program provides an opportunity to enhance the practitioner’s knowledge about the practical aspects of stereotactic radiosurgery using the Gamma Knife IconTM. Participants will review clinical implications and clinical outcomes of radiosurgery, identify radiation safety principals, and apply treatment planning considerations and principals of stereotactic radiosurgery treatment hardware. As part of Miami Cancer Institute’s internationally recognized radiation oncology program, our team of experts offers a non-surgical radiation treatment called Gamma Knife radiosurgery – the most modern technology available – in South Florida’s only state-of-the-art Icon Gamma Knife Center. Learn more

Complete details at MiamiCancerInstitute.com/GammaKnifeMiami

Target Audience

Neurosurgeons, medical physicists, radiation oncologists and neuro-otolaryngologists.

Authorized Training Participants (Trainees) are limited to individuals from institutions that have already purchased the Gamma Knife Icon™.  These sessions are not open to individuals from institutions that are prospective customers who seek training prior to purchasing the Gamma Knife Icon™.  

Learning Objectives

  • Recognize the basic principles and physics of radiosurgery and how they relate to day-to-day patient treatment.
  • Review the clinical implications, treatment parameters and clinical outcomes of radiosurgery.
  • Identify radiation safety principles and potential issues of radiosurgery and review emergency procedures.
  • Apply principles of stereotactic frame and mask application, imaging and radiosurgery treatment hardware. ​
Course summary
Course opens: 
03/29/2019
Course expires: 
12/31/2020
Event starts: 
01/13/2020 - 8:00am
Event ends: 
01/16/2020 - 5:00pm
Cost:
$6,500.00
Rating: 
0
Miami Cancer Institute
8900 N. Kendall Dr.
Department of Radiation Oncology
Miami, FL 33176
United States

Travel

Accommodations

Hilton Miami Dadeland

9100 N. Kendall Dr., Miami, FL 33176, (786) 979-1920

The Hilton Miami Dadeland is adjacent to the Baptist Hospital campus and convenient from MIA (13 miles) and FLL Airports (30 miles). Reserve your room at the corporate rate plus applicable taxes by referencing Group Code, N3195087, at MiamiDadeland.Hilton.com or 786-975-1920. Rates are seasonal and based on availability. Applicable taxes will apply.

Room Rates        Course Dates

$174                      January 13-17, 2020*

*Based on 2019 rate schedule and is subject to change.

Location! Location! Location!
The Hilton Miami Dadeland is ideally located in the heart of South Miami-Dade's hottest attractions. Just ten minutes away is the area’s most iconic shopping center, Dadeland Mall. You’ll find great dining options there and across the street at the Downtown Dadeland pedestrian neighborhood. From the nearby Dadeland South Metrorail station you can connect to downtown Miami, Brickell City Center and Miami International Airport.

Outdoor lovers will appreciate Fairchild Tropical Botanic Gardens, Everglades National Park, and Zoo Miami, the largest and oldest zoological garden in Florida and the only sub-tropical zoo in the continental United States. The neighboring popular hot spots of Coral Gables, Coconut Grove, South Beach and The Florida Keys are just a short drive away. For additional tourist information, including a host of annual art festivals and events, please visit miamiandbeaches.com.

Course Directors: 
Rupesh Kotecha, M.D.,
Chief of Radiosurgery, Miami Cancer Institute
Minesh Mehta, M.D., Deputy Director and Chief of Radiation Oncology, Miami Cancer Institute
Sergio Gonzalez-Arias, M.D., Chief, Department of Neuroscience - Baptist Hospital of Miami
Chair, Department of Neuroscience, and Executive Associate Dean for Clinical Affairs
Florida International University Herbert Wertheim College of Medicine

Speakers, Faculty, Instructors:
Kevin Abrams, M.D., Chief of Radiology, Medical Director of Neuroradiology, Baptist Health South Florida
Clinical Associate Professor of Radiology
Florida International University Herbert Wertheim School of Medicine

Haley Appel, MMS, PA-C, Physician Assistant Radiation Oncology, Miami Cancer Institute

Michael Chuong, M.D., Director of Clinical Research and Education, Miami Cancer Institute

Jerry George, Ph.D., Radiation Safety Officer, Miami Cancer Institute

Andrew Godley, Ph.D., Sr. Medical Physicist, , Miami Cancer Institute

Alonso Gutierrez, Ph.D. AVP, Chief Physicist, Radiation Oncology, , Miami Cancer Institute

Matthew Hall, M.D., Lead Pediatric Radiation Oncologist, Miami Cancer Institute

Susan Lohman, Clinical Applications Manager, Elekta 

Clare Morales, R.N., Advanced Radiation Oncology Nurse, Miami Cancer Institute

Yazmin Odia, M.D., Lead Physician of Medical Neurologic Oncology, Miami Cancer Institute

Vitaly Siomin, M.D., Medical Director of the Brain Tumor Program, Baptist Health Neuroscience Center

Michael Vogelbaum M.D. Ph.D. – Program Leader, Department of Neuro-Oncology, Moffitt Cancer Center

D. Jay M. Wieczorek, Ph.D., Senior Medical Physicist, Department of Radiation Oncology, Miami Cancer Institute

Kevin Abrams, M.D., has disclosed that he serves as a consultant for Keystone Heart and stock shareholder for Keystone Heart and Cleerly. Dr. Abrams has also indicated that his presentation will not include discussion of off-label or unapproved usage.

Matthew D. Hall , M.D., MBA has disclosed that he has received an honorarium from  Viewray, Inc. Dr. Hall has also indicated that his presentation will not include discussion of off-label or unapproved usage.

Rupesh Kotecha, M.D.,  has disclosed that he has received honorariums from Elekta, Elsevier and ACCURAY, Inc., serves on the Clinical Advisory Boards for ACCURAY, Inc., Novocure and Abbvie. Dr. Kotecha has also indicated that his presentation will not include discussion of off-label or unapproved usage.

Minesh P. Mehta, M.D., FASTRO, has disclosed that he is on the Board of Directors for Oncoceutics, serves on the Medical Advisory Boards for Colby, Stemina and Procertus and is a consultant for Celgene, Tocagen, Abbvie and Astra Zeneca. Dr. Mehta
has also indicated that his presentation will not include discussion of off-label or unapproved usage.

Yazmin Odia, M.D., has disclosed that she has received grant and research support from BMS, Novocure and Oncoceutics and serves as a consultant for Oncoceutics. Dr. Odia has indicated that her presentation will include discussion of off-label and unapproved usage.

Michael A. Vogelbaum, M.D., Ph.D., has disclosed that he is a consultant for Tocagen, Celgene and Blue Earth, he also receives royalties form Infusean Therapeutics.  Dr. Vogelbaum has indicated that his presentation will not include discussion of off-label or unapproved usage.

Haley Appel, MMC, Michael Chuong, M.D., Jerry George, M.D. Andrew Godley, M.D., Sergio Gonzalez-Arias, M.D., Alonso Gutierrez, Ph.D., Vitaly Siomin, M.D. and D. Jay Wieczorek, Ph.D. have nothing to disclose and their presentations will not include discussion of off label or unapproved usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 31 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MCI has applied to CAMPEP for approval of 30 MPCEC hours for this training.

Available Credit

Accreditation Period

Course opens: 
03/29/2019
Course expires: 
12/31/2020

Price

Cost:
$6,500.00
Please login or register to take this course.

ELIGIBILITY:  Participants are limited to individuals from institutions that have already purchased a Gamma Knife™.  These sessions are not open to individuals from institutions that are prospective customers who seek training prior to purchasing a Gamma Knife™. You will be asked to provide your institution affiliation during the registration process. 

Registration options for eligible participants are based on prior training. 
Eligible Participants with NO PRIOR TRAINING:
Obtain a Registration Code by contacting Reagan Greco, training center coordinator, at ReaganG@baptisthealth.net or 786-527-7909. After you receive your registration code, please proceed with the registration process through the link just below. 
Eligible Participants WITH PRIOR TRAINING: Please proceed with the registration process through the link below. 

Register online (Master Card, Visa, American Express or by Check*)
*If paying by check: Register now to reserve your place in the course.

Checks should be made payable to:
Baptist Health South Florida
ATTN: CME Dept/Gamma Knife
8900 N. Kendall Dr.
Miami, FL 33176

Payment must be received no later than 30 days prior to the start date of the course. Payment instructions will be emailed to you after you complete online enrollment.

Required Hardware/software

If you are only seeing this message, please look in the upper right hand and see if there is something in your shopping cart.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support